BNP Paribas Financial Markets
TARS icon

BNP Paribas Financial Markets’s Tarsus Pharmaceuticals TARS Stock Holding History

BNP Paribas Financial Markets’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.7M Sell
201,624
-101,885
-34% -$6.51M ﹤0.01% 1497
2026
Q1 		$21.3M Sell
303,509
-52,596
-15% -$3.68M 0.01% 1115
2025
Q4 		$29.2M Buy
356,105
+151,805
+74% +$11.3M 0.01% 962
2025
Q3 		$12.1M Buy
204,300
+51,991
+34% +$2.56M 0.01% 1421
2025
Q2 		$6.17M Buy
152,309
+76,601
+101% +$3.45M ﹤0.01% 1743
2025
Q1 		$3.89M Buy
75,708
+70,860
+1,462% +$3.5M ﹤0.01% 1964
2024
Q4 		$268K Buy
+4,848
New +$220K ﹤0.01% 3696

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BNP Paribas Financial Markets's TARS Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Tarsus Pharmaceuticals (TARS) stake by 34% in Q2 2026, selling an estimated $6.51M and leaving 201,624 shares worth $12.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1497.

BNP Paribas Financial Markets first reported a position in TARS in Q4 2024 and has held it in 7 quarters since. The position peaked at $29.2M in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • BNP Paribas Financial Markets held 201,624 shares of Tarsus Pharmaceuticals worth $12.7M as of Q2 2026.
  • BNP Paribas Financial Markets sold 101,885 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $6.51M.
  • Tarsus Pharmaceuticals made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #1497 holding.
  • BNP Paribas Financial Markets first reported a position in Tarsus Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's Tarsus Pharmaceuticals position peaked at $29.2M in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.